Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 345


Review of outcomes associated with restricted access to atypical antipsychotics.

Rajagopalan K, Hassan M, Boswell K, Sarnes E, Meyer K, Grossman F.

Am J Manag Care. 2016 Jun 1;22(6):e208-14.


Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.

Awad G, Ng-Mak D, Rajagopalan K, Hsu J, Pikalov A, Loebel A.

BMC Psychiatry. 2016 Jun 1;16:176. doi: 10.1186/s12888-016-0879-5.


Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.

Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.

BMC Psychiatry. 2016 May 23;16:157. doi: 10.1186/s12888-016-0865-y.


Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.

Rajagopalan K, Trueman D, Crowe L, Squirrell D, Loebel A.

Pharmacoeconomics. 2016 Jul;34(7):709-21. doi: 10.1007/s40273-016-0405-0.


The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.

Rajagopalan K, Bacci ED, Wyrwich KW, Pikalov A, Loebel A.

Int J Bipolar Disord. 2016 Dec;4(1):7. doi: 10.1186/s40345-016-0049-1.


Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update.

Mooney SM, Rajagopalan K, Rangarajan G, Kulkarni P.

Asian J Androl. 2016 Sep-Oct;18(5):711-2. doi: 10.4103/1008-682X.174858. No abstract available.


Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression.

Calabrese J, Rajagopalan K, Ng-Mak D, Bacci ED, Wyrwich K, Pikalov A, Loebel A.

Int Clin Psychopharmacol. 2016 May;31(3):147-54. doi: 10.1097/YIC.0000000000000116.


Lurasidone in Adults with Schizophrenia in the UK: A Cost Consequence Analysis Considering Cost Implications of Improved Efficacy and Safety.

Rajagopalan K, Trueman D, Crowe L, Patel P, Loebel A.

Value Health. 2015 Nov;18(7):A408. doi: 10.1016/j.jval.2015.09.967. No abstract available.


Cost-Utility and Budget Impact Analyses Comparing Lurasidone with Aripiprazole in Adults with Schizophrenia in Scotland.

Rajagopalan K, Trueman D, Crowe L, Patel P, Loebel A.

Value Health. 2015 Nov;18(7):A408-9. doi: 10.1016/j.jval.2015.09.968. No abstract available.


Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.

Loebel A, Siu C, Rajagopalan K, Pikalov A, Cucchiaro J, Ketter TA.

J Affect Disord. 2015 Nov 1;186:376-82. doi: 10.1016/j.jad.2015.07.033.


Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen.

He Y, Chen Y, Mooney SM, Rajagopalan K, Bhargava A, Sacho E, Weninger K, Bryan PN, Kulkarni P, Orban J.

J Biol Chem. 2015 Oct 9;290(41):25090-102. doi: 10.1074/jbc.M115.658583.


Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells.

Rajagopalan KN, Egnatchik RA, Calvaruso MA, Wasti AT, Padanad MS, Boroughs LK, Ko B, Hensley CT, Acar M, Hu Z, Jiang L, Pascual JM, Scaglioni PP, DeBerardinis RJ.

Cancer Metab. 2015 Jun 29;3:7. doi: 10.1186/s40170-015-0134-4.


Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.

Rajagopalan K, Meyer K, O'Day K, Denno M, Loebel A.

J Med Econ. 2015;18(10):821-7. doi: 10.3111/13696998.2015.1052462.


Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a decade of progress and hopeful future.

Rajagopalan K, Govindan R.

J Thorac Dis. 2015 Mar;7(3):217-9. doi: 10.3978/j.issn.2072-1439.2015.01.53. No abstract available.


Chemotherapy advances in locally advanced head and neck cancer.

Georges P, Rajagopalan K, Leon C, Singh P, Ahmad N, Nader K, Kubicek GJ.

World J Clin Oncol. 2014 Dec 10;5(5):966-72. doi: 10.5306/wjco.v5.i5.966. Review.


Structure of the Arabidopsis thaliana TOP2 oligopeptidase.

Wang R, Rajagopalan K, Sadre-Bazzaz K, Moreau M, Klessig DF, Tong L.

Acta Crystallogr F Struct Biol Commun. 2014 May;70(Pt 5):555-9. doi: 10.1107/S2053230X14006128.


Gold nanoparticles electroporation enhanced polyplex delivery to mammalian cells.

Huang S, Deshmukh H, Rajagopalan KK, Wang S.

Electrophoresis. 2014 Jul;35(12-13):1837-45. doi: 10.1002/elps.201300617.


Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K.

BMC Psychiatry. 2014 Feb 23;14:53. doi: 10.1186/1471-244X-14-53.


Cancer/testis antigen PAGE4, a regulator of c-Jun transactivation, is phosphorylated by homeodomain-interacting protein kinase 1, a component of the stress-response pathway.

Mooney SM, Qiu R, Kim JJ, Sacho EJ, Rajagopalan K, Johng D, Shiraishi T, Kulkarni P, Weninger KR.

Biochemistry. 2014 Mar 18;53(10):1670-9. doi: 10.1021/bi500013w.


Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.

Bollu V, Ernst FR, Karafilidis J, Rajagopalan K, Robinson SB, Braman SS.

Int J Chron Obstruct Pulmon Dis. 2013;8:631-9. doi: 10.2147/COPD.S52557.

Items per page

Supplemental Content

Loading ...
Support Center